Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
157.77
+2.84 (1.83%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $2.27 billion as of August 7, 2026. Its market cap has increased by 426.27% in one year.
Market Cap
2.27B
Enterprise Value
2.05B
1-Year Change
426.27%
Ranking
Category
Stock Price
$157.77
ChartMarket Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $2.27B, an increase of 1,478.96%. That is a compound annual growth rate of 437.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 2.27B | 83.48% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mineralys Therapeutics | 2.38B |
| Vera Therapeutics | 2.37B |
| SELLAS Life Sciences Group | 2.35B |
| Vericel | 2.32B |
| Sionna Therapeutics | 2.30B |
| ADMA Biologics | 2.27B |
| Rapport Therapeutics | 2.27B |
| UroGen Pharma | 2.26B |